The Life Sciences sector has also developed considerably since the promulgation of the Clinical Trials Act 2011 with trials being carried out on various pathologies such as diabetes, cardiology, and HIV/AIDS. To date, over 80 clinical trials have been conducted with the contribution of some 15,000 volunteers whilst ensuring the required quality check in line with international standards.
Mauritius is embarking in the exploration of various biotechnology spheres involving immunology, plant biotechnology and genetics. The medical biotechnology sector accounts for a turnover in excess of MUR 2.3 billion and there are currently 5 Contract Research Organizations operating on the island and carrying out trials on various pathologies including hepatitis, diabetes, HIV amongst others.
The multi-ethnic population demographics prevailing in Mauritius provides the appropriate climate and hence an opportunity for running clinical trials. In addition, being characterised with having a rich biodiversity, Mauritius is well placed to develop the nutraceutical industry for the potential use against chronic diseases.
Through a panoply of schemes and unique incentives offered, EDB Mauritius supports the expansion and growth of business operations as a way to enhance substantive and value-added economic activities in Mauritius.
Medew Holdings Ltd
Setting up in Mauritius means joining a long list of world-class businesses that have chosen our country as their regional base of operations. These exceptional businesses include: